Tag: philips

Philips launches QuickClear mechanical thrombectomy system for blood clot removal in...

Royal Philips has announced the launch of the QuickClear mechanical thrombectomy system. The single-use system delivers an all-in-one aspiration pump and catheter to remove...

The value of IVUS in endovascular procedures

In this supplement, sponsored by Philips: Paul Gagne explains how intravascular ultrasound (IVUS) can be used to guide the treatment of chronic venous disease,...

Philips to expand its image-guided therapy portfolio through acquisition of Intact...

Royal Philips today announced that it has signed an agreement to acquire Intact Vascular. According to a press release, Intact Vascular will enhance Philips’...

New data reconfirm long-term safety profile of the Philips Stellarex low-dose...

Royal Philips recently announced the four-year results from the ILLUMENATE European randomised controlled trial (EU RCT). The Stellarex drug-coated balloon (DCB) cohort demonstrated similar...

Philips and the US government collaborate in ventilator production ramp up...

Royal Philips has announced that the US government and Philips agreed to team up to increase the production of hospital ventilators in its manufacturing...

New developments in intraoperative navigation show “revolutionary” potential

The early months of 2020 have seen the emergence of new technologies in the intraoperative navigation space. Here, Vascular News considers Philips’ Fiber Optic...

LINC 2020: Four-year ILLUMENATE data reaffirm safety profile of Stellarex

Philips today announced four-year results from the randomised controlled ILLUMENATE pivotal trial in the USA. The data show similar mortality rates through four years...

VEITH 2019: Fiber Optic RealShape (FORS) technology could spark a new...

Joost van Herwaarden (Utrecht, The Netherlands) and Tilo Kölbel (Hamburg, Germany) discuss the current challenges of image-guided therapy—primarily regarding the limiting factor of having...

Philips receives FDA approval for low-dose drug-coated balloons

Philips has received US Food and Drug Administration (FDA) approval for two Stellarex 0.035” low-dose (200mm and 150mm) drug-coated balloons for the treatment of...

Late-breaking ILLUMENATE data demonstrate three-year safety and efficacy for Stellarex DCB

Three-year results from the ILLUMENATE Pivotal trial and the ILLUMENATE European randomised controlled trial (EU RCT) have been presented in a late-breaking trial session...

Augmented reality surgical technology unveiled by Philips and Microsoft

At the MWC (25–26 February, Barcelona, Spain), formerly the Mobile World Congress, Philips unveiled a unique mixed reality concept developed in partnership with Microsoft for...
Zenition

Philips launches Zenition mobile C-arm platform

Philips Zenition, a new mobile C-arm imaging platform from Philips, has launched in the USA, Germany, Austria and Switzerland. It is being introduced into...

New data release at LINC 2019 reinforces safety profile of low-dose...

 Sean Lyden (Cleveland, USA) and Fabrizio Fanelli (Rome, Italy) discuss the safety and future of drug-coated balloons (DCB) in light of the latest pooled...

Philips launces Azurion with FlexArm to aid image-guided procedures

Philips launches its Azurion with FlexArm to aid patient imaging and positioning during image-guided procedures. During increasingly complex interventions, clinicians need to quickly and easily...
Azurion

Philips launches Azurion with FlexArm to aid image-guided procedures

Philips launches its Azurion with FlexArm platform to aid patient imaging and positioning during image-guided procedures. Azurion with FlexArm allows clinicians to intraoperatively visualise patient...

First US patient enrolled in ILLUMENATE BTK study of Stellarex 0.014...

The first US patient has been enrolled in the Stellarex ILLUMENATE below-the-knee (BTK) investigational device exemption (IDE) study, led by principal investigators Bill Gray...

Similar patency outcomes in women and men treated with Stellarex DCB

A study presented at VIVA 2018 (5–8 November, Las Vegas, USA) by Maureen Kohi, associate professor of Clinical Radiology, University of California, San Francisco,...
Azurion

Image-guided therapy platform benefits clinical workflow and staff experience

Philips has announced the results of an independent two-year study on clinicians' use of Azurion, the company's image-guided therapy platform, at St. Antonius Hospital....

Merging the portfolios and strengths of Philips and Spectranetics

At the recent Vascular Interventional Advances 2017 conference (VIVA; 11–14 September, Las Vegas, USA), Vascular News caught up with Philips' Atul Gupta (Global Chief...

Two-year efficacy of Philips’ Stellarex 0.035” low-dose drug-coated balloon demonstrated

Philips has announced the two-year results from the ILLUMENATE European randomised clinical trial (EU RCT) demonstrating the efficacy of the Philips Spectranetics’ Stellarex 0.035”...

Philips completes acquisition of Spectranetics

Philips has completed the acquisition of Spectranetics. Spectranetics’ financial results will be consolidated as part of Philips’ Image-Guided Therapy business group as of August...

Philips acquires CardioProlific

  Royal Philips has announced the acquisition of CardioProlific Inc, a USA-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease. Financial...

Philips to acquire Spectranetics

Royal Philips and The Spectranetics Corporation have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commence a tender offer to acquire all of...

Philips announces the relaunch of the Pioneer Plus catheter

Philips has announced the relaunch of its Pioneer Plus catheter, “the first and only re-entry device with intravascular ultrasound (IVUS) capabilities and needle deployment designed...

Philips launches Azurion worldwide

Philips has announced the global launch of Azurion, its next generation image-guided therapy platform that integrates advanced interventional tools into one clinician platform. Azurion...

Improving patient outcomes in today’s cost-controlled health systems

Atul Gupta, MD, Interventional Radiologist and Chief Medical Officer, Philips Image Guided Therapy Our roles as interventionalists have been transformed over the past 20 years....